What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-02-27 compared with 2025-03-10 · 23 added, 31 removed, 3 unchanged (95% of the section changed)

ITEM 5 MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is listed for trading on the Nasdaq under the symbol “MCVT”.

Our Common Stock is listed for trading on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “SUIG”.

The transfer agent and registrar for our Common Stock is Pacific Stock Transfer Company, 6725 Via Austi Parkway, Suite 300, Las Vegas, NV 89119.

The following table sets forth the high and low bid prices for our common stock as reported on the Nasdaq Capital Market.

Market Price (High/Low)

First Quarter

$ 2.27 – 3.01

Second Quarter

$ 2.50 - 3.01

$ 2.44 – 2.17

Third Quarter

$ 2.25 – 3.56

$ 3.58 – 2.09

Fourth Quarter

$ 1.79 – 2.26

$ 3.59 – 2.22

As of the date of this filing, we had approximately 185 holders of record of our Common Stock and shares held in street name by approximately 178 non-objecting beneficial owners.

We do not expect that the Board of Directors will declare any cash dividends in the foreseeable future.

Securities Authorized for Issuance Under Equity Compensation Plans

Plan category

Number of securities to be issued upon exercise of outstanding options, warrants and rights

Weighted-average exercise price of outstanding options, warrants and rights

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

Equity compensation plans approved by security holders

Equity compensation plans not approved by security holders

The securities reflected in column (a) above were issued pursuant to the company’s 2022 Stock Incentive Plan.

Recent Sales of Unregistered Securities

In November and December 2022, the Company issued options for the purchase of an aggregate of 870,000 shares of common stock to officers, directors and employees of, and consultants to, the Company contemporaneously with the adoption of a 2022 Stock Incentive Plan.

These option grants were made subject to subsequent shareholder approval of the 2022 Stock Incentive Plan in accordance with Nasdaq rules.

The options were granted pursuant to Section 4(a)(2) of the Securities Act of 1933 and other applicable exemptions.

The shareholders of the company subsequently approved the 2022 Stock Incentive Plan on January 20, 2023 at a special meeting of shareholders called for that purpose.

Options for 200,000 of these common shares were subsequently exercised, and the common shares issued, in September 2023.

No options were exercised in 2024.

We do not expect that the Board will declare any cash dividends in the foreseeable future.

See “Item 12 — Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters - Securities Authorized for Issuance Under Equity Compensation Plans” below for further details regarding equity compensation plans.

Recent Purchases of Equity Securities by the Issuer

The following table provides information about Company purchases of equity securities that are registered by the Company pursuant to Section 12 of the Exchange Act during the quarter ended December 31, 2025:

of Shares Purchased (1)

Weighted Average

Price Paid Per Share

Total Number of

Shares Purchased as

Part of Publicly

Announced Plans

Maximum Dollar

Value of Shares

(in millions) Under

October 1–30, 2025

November 1–30, 2025

December 1–31, 2025

(1) Represents share repurchases under the Company’s previously announced $50 million stock repurchase program (the “New Program”).

(2) Represents approximate dollar value of shares that were available to be purchased under the New Program as of December 31, 2025.

The Program does not have a specific expiration date.

During the year ended December 31, 2025, 8,077,337 shares had been repurchased under the New Program (including 276,296 shares repurchased during the quarter ended September 30, 2025), and 641,225 shares had been repurchased under the Company’s prior $2.0 million stock repurchase program, exhausting all remaining capacity under that program.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity